• / Free eNewsletters & Magazine
  • / My Account

JASDAQ

  1. R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Cerebral Infarction Utilizing VAP-1 Inhibitor (RTU-009) with Autonomous University of Barcelona and Vall d'Hebron ...

    R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Cerebral Infarction Utilizing VAP-1 Inhibitor (RTU-009) with Autonomous University of Barcelona and Vall d'Hebron Institute of Research

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.